Literature DB >> 31549881

Immune Infiltration Profiling in Nonsmall Cell Lung Cancer and Their Clinical Significance: Study Based on Gene Expression Measurements.

Fangyao Chen1, Yuhui Yang2, Yaling Zhao1, Leilei Pei1, Hong Yan1,3,4.   

Abstract

Immune cell infiltration is associated with the prognosis of cancer. This study focused on the immune infiltration profiling and their association with survival outcome in nonsmall cell lung cancer (NSCLC). Research data were obtained from the Gene Expression Omnibus and The Cancer Genome Atlas databases. CIBERSORT algorithm was applied to assess the relative proportions of 22 kinds of immune cells. Log-rank test was performed to compare the survival outcome of patients with different proportions of immune cells. The estimated hazard ratios were presented with forest plot. Multivariate Cox regression analysis was conducted to estimate the adjusted associations between different types of infiltrating immune cells and survival prognosis controlling for other clinical features and confounders. With the CIBERSORT approach, we assessed the proportions of 22 infiltrating immune cells of 2050 cases with NSCLC. By conducting survival analysis, we found different survival outcomes among cases with different proportions of certain types of infiltrating immune cells. Among the cell subsets investigated, plasma cells (hazard ratio [HR] = 0.775, 95% confidence interval [CI]: 0.669-0.898) and regulatory T cells (HR = 1.258, 95% CI: 1.091-1.451) were associated with survival outcome of NSCLC patients controlling for other covariates. Subgroup analysis suggested a good consistency and robustness of our results. Our findings might provide useful information for prognosis prediction and cellular study in NSCLC.

Entities:  

Keywords:  gene signature; immune infiltration; nonsmall cell lung cancer; survival

Mesh:

Year:  2019        PMID: 31549881     DOI: 10.1089/dna.2019.4899

Source DB:  PubMed          Journal:  DNA Cell Biol        ISSN: 1044-5498            Impact factor:   3.311


  7 in total

1.  An immunosuppressive scoring system to predict recurrence and assist in decision regarding postoperative adjuvant treatment in gastric cancer.

Authors:  Jiabin Wang; Qingzhu Qiu; Ningzi Lian; Huagen Wang; Qiaoling Zheng; Yinghong Yang; Yubin Ma; Yajun Zhao; Ping Li; Jianxian Lin; Jun Lu; Qiyue Chen; Longlong Cao; Mi Lin; Changming Huang; Jianwei Xie
Journal:  Am J Cancer Res       Date:  2022-05-15       Impact factor: 5.942

2.  DNA repair genes are associated with tumor tissue differentiation and immune environment in lung adenocarcinoma: a bioinformatics analysis based on big data.

Authors:  Jiayin Li; Jingxu Zhou; Jing Zhang; Zhiwei Xiao; Wenping Wang; Hanrui Chen; Lizhu Lin; Qiuye Yang
Journal:  J Thorac Dis       Date:  2021-07       Impact factor: 3.005

3.  KRT8 Serves as a Novel Biomarker for LUAD and Promotes Metastasis and EMT via NF-κB Signaling.

Authors:  Hao Chen; Xiaobin Chen; Bo Pan; Chutian Zheng; Liangjie Hong; Weili Han
Journal:  Front Oncol       Date:  2022-05-19       Impact factor: 5.738

4.  A Novel Nomogram Based on Immune Scores for Predicting Survival in Patients with Early-Stage Non-Small Cell Lung Cancer (NSCLC).

Authors:  Zhulin Wu; Chensheng Ouyang; Lisheng Peng
Journal:  Med Sci Monit       Date:  2020-06-01

5.  Machine Learning Analysis of Immune Cells for Diagnosis and Prognosis of Cutaneous Melanoma.

Authors:  Huibin Du; Yan He; Wei Lu; Yu Han; Qi Wan
Journal:  J Oncol       Date:  2022-01-27       Impact factor: 4.375

6.  Immune Infiltration Analysis with the CIBERSORT Method in Lung Cancer.

Authors:  Meng Guan; Yan Jiao; Lili Zhou
Journal:  Dis Markers       Date:  2022-03-18       Impact factor: 3.434

7.  Systematic analysis of expression profiles of HMGB family members for prognostic application in non-small cell lung cancer.

Authors:  Xuefeng Zheng; Xu Wang; Yunduan He; Hong Ge
Journal:  Front Mol Biosci       Date:  2022-07-18
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.